Arch Financial Statements From 2010 to 2024

Stocks . Canada . 
Stock . Arch Biopartners
ARCH Stock  CAD 1.77  0.05  2.91%   
Arch Biopartners financial statements provide useful quarterly and yearly information to potential Arch Biopartners investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Arch Biopartners financial statements helps investors assess Arch Biopartners' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Arch Biopartners' valuation are summarized below:
Gross Profit
-502.9 K
Profit Margin
(1.86)
Market Capitalization
129.9 M
Enterprise Value Revenue
53.0545
Revenue
1.4 M
There are over one hundred nineteen available fundamental signals for Arch Biopartners, which can be analyzed over time and compared to other ratios. All traders should should validate Arch Biopartners' prevailing fundamental trends against the trends from 2010 to 2024 to make sure the company is sustainable. Market Cap is likely to drop to about 5.8 M in 2024. Enterprise Value is likely to drop to about 7.2 M in 2024

Arch Biopartners Total Revenue

2.4 Million

Check Arch Biopartners financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Arch Biopartners' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.5 M, Total Revenue of 2.4 M or Other Operating Expenses of 6.3 M, as well as many indicators such as Price To Sales Ratio of 1.78, Dividend Yield of 0.0 or Days Sales Outstanding of 17.29. Arch financial statements analysis is a perfect complement when working with Arch Biopartners Valuation or Volatility modules.
  
This module can also supplement various Arch Biopartners Technical models . Check out the analysis of Arch Biopartners Correlation against competitors.

Arch Biopartners Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets588.8 K1.1 M661.6 K
Slightly volatile
Total Current Liabilities7.2 M6.9 M2 M
Slightly volatile
Property Plant And Equipment Net149.8 K168.6 K139.3 K
Slightly volatile
Accounts Payable410.7 K452.4 K361.9 K
Slightly volatile
Cash1 M956 K445 K
Slightly volatile
Cash And Short Term Investments1 M956 K445 K
Slightly volatile
Common Stock Shares Outstanding41.8 M71.8 M52.3 M
Slightly volatile
Liabilities And Stockholders Equity588.8 K1.1 M661.6 K
Slightly volatile
Other Current Assets39.8 K49.5 K39.6 K
Pretty Stable
Other Stockholder Equity6.3 M6 M3 M
Slightly volatile
Total Liabilities8.1 M7.7 M3.1 M
Slightly volatile
Total Current Assets1.4 M1.3 M713.2 K
Slightly volatile
Intangible Assets9.5 K10 K13 K
Slightly volatile
Short Term Investments986 K939 K458.1 K
Slightly volatile
Short and Long Term Debt Total6.1 M5.8 M2.4 M
Slightly volatile
Net Receivables337.1 K341.4 K248.1 K
Slightly volatile
Short Term Debt5.2 M5 M1.7 M
Slightly volatile
Non Current Liabilities Total1.3 M809.5 K1.2 M
Slightly volatile
Common Stock11.4 M18.3 M11.2 M
Slightly volatile
Long Term Investments0.80.90.98
Slightly volatile
Short and Long Term Debt5.2 M5 M1.8 M
Slightly volatile
Other Liabilities284.4 K321.3 K269.1 K
Slightly volatile
Long Term Debt769 K809.5 K1.2 M
Slightly volatile
Capital Stock15.4 M18.3 M13.3 M
Slightly volatile

Arch Biopartners Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization3.5 M3.3 M1.5 M
Slightly volatile
Other Operating Expenses6.3 M6 M2.4 M
Slightly volatile
Total Operating Expenses6.3 M6 M2.4 M
Slightly volatile
Selling General Administrative763.7 K439.3 K795.2 K
Slightly volatile
Selling And Marketing Expenses6.1 K6.5 K30.6 K
Pretty Stable
Interest Expense433.4 K412.8 K150 K
Slightly volatile
Research Development2.7 M2.5 M1.2 M
Slightly volatile

Arch Biopartners Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Change In Working Capital253.2 K241.1 K208.9 K
Slightly volatile
Begin Period Cash Flow611.4 K582.3 K352.4 K
Slightly volatile
Depreciation48.6 K51.1 K45.3 K
Slightly volatile
End Period Cash Flow1 M956 K445.1 K
Slightly volatile
Sale Purchase Of Stock496.1 K553.5 K633.4 K
Slightly volatile
Issuance Of Capital Stock109.4 K115.2 K1.1 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.781.8691391
Slightly volatile
Days Sales Outstanding17.2918.1988284
Slightly volatile
Average Payables284.8 K430.7 K309.1 K
Slightly volatile
Stock Based Compensation To Revenue1.081.144.027
Pretty Stable
Capex To Depreciation3.431.861.6842
Slightly volatile
EV To Sales2.22.318403
Slightly volatile
Payables Turnover1.92.15442.8799
Slightly volatile
Sales General And Administrative To Revenue0.130.13247.0958
Pretty Stable
Research And Ddevelopement To Revenue0.840.887.2401
Very volatile
Capex To Revenue0.06480.06820.0089
Slightly volatile
Cash Per Share1.0E-41.0E-40.007
Pretty Stable
Days Payables Outstanding178169160
Slightly volatile
Income Quality0.330.3820.6858
Pretty Stable
Intangibles To Total Assets0.320.30.2545
Slightly volatile
Current Ratio0.00440.00462.0789
Slightly volatile
Receivables Turnover21.0620.05634.7208
Slightly volatile
Graham Number0.30.22870.1484
Slightly volatile
Capex Per Share1.0E-41.0E-40.0
Slightly volatile
Average Receivables77.9 K82 K158.8 K
Pretty Stable
Revenue Per Share0.140.13380.0264
Slightly volatile
Interest Debt Per Share0.0680.06470.0371
Slightly volatile
Debt To Assets2.712.06094.6752
Slightly volatile
Days Of Payables Outstanding178169160
Slightly volatile
Ebt Per Ebit26.8925.61014.375
Slightly volatile
Quick Ratio0.00440.00462.1173
Slightly volatile
Net Income Per E B T0.961.01234.1732
Slightly volatile
Cash Ratio0.00430.00461.899
Slightly volatile
Days Of Sales Outstanding17.2918.1988284
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.261.00371.0176
Slightly volatile
Fixed Asset Turnover23.5722.4423.0668
Slightly volatile
Debt Ratio2.712.06094.6752
Slightly volatile
Price Sales Ratio1.781.8691391
Slightly volatile
Asset Turnover4.814.58531.207
Slightly volatile

Arch Biopartners Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap5.8 M6.1 M44.7 M
Pretty Stable
Enterprise Value7.2 M7.6 M46 M
Pretty Stable

Arch Fundamental Market Drivers

Cash And Short Term Investments831.3 K

About Arch Biopartners Financial Statements

Arch Biopartners investors use historical fundamental indicators, such as Arch Biopartners' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Arch Biopartners. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue1.3 M1.3 M
Total Revenue2.3 M2.4 M
Cost Of Revenue2.4 M1.3 M
Stock Based Compensation To Revenue 1.14  1.08 
Sales General And Administrative To Revenue 0.13  0.13 
Research And Ddevelopement To Revenue 0.88  0.84 
Capex To Revenue 0.07  0.06 
Revenue Per Share 0.13  0.14 
Ebit Per Revenue(0.09)(0.10)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Arch Stock Analysis

When running Arch Biopartners' price analysis, check to measure Arch Biopartners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arch Biopartners is operating at the current time. Most of Arch Biopartners' value examination focuses on studying past and present price action to predict the probability of Arch Biopartners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arch Biopartners' price. Additionally, you may evaluate how the addition of Arch Biopartners to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY